πŸ‡ΊπŸ‡Έ FDA
Patent

US 6689778

Inhibitors of Src and Lck protein kinases

expired A61PA61P1/04A61P1/16

Quick answer

US patent 6689778 (Inhibitors of Src and Lck protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/00, A61P11/06